MedTrace Logo

High Dose Vitamin D vs Standard Dose Vitamin D Study

NCT01988090 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 93

Last updated 2021-08-09

Study results available
· View outcomes & findings →

Summary

This study is being done to look at the difference, if there is a difference between two different doses of Vitamin D and the reduction of joint/muscle pain (arthralgia)that is caused by taking anti-estrogen medications (aromatase inhibitors) by breast cancer patients. The investigators hope to learn if taking a higher dose of Vitamin D is a good way to prevent aromatase inhibitor arthralgia (AIA).

Conditions

Interventions

DRUG

800 IU Vitamin D Supplement

Standard Dose

DRUG

50,000 IU Vitamin D supplement

High Dose

Sponsors & Collaborators

  • Mothaffar Rimawi

    lead OTHER

Principal Investigators

  • Mothaffar Rimawi, MD · Baylor College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2018-07-21
Completion
2018-12-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01988090 on ClinicalTrials.gov